Document Detail


Impact of cardiac support device combined with slow-release prostacyclin agonist in a canine ischemic cardiomyopathy model.
MedLine Citation:
PMID:  24131787     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The cardiac support device supports the heart and mechanically reduces left ventricular (LV) diastolic wall stress. Although it has been shown to halt LV remodeling in dilated cardiomyopathy, its therapeutic efficacy is limited by its lack of biological effects. In contrast, the slow-release synthetic prostacyclin agonist ONO-1301 enhances reversal of LV remodeling through biological mechanisms such as angiogenesis and attenuation of fibrosis. We therefore hypothesized that ONO-1301 plus a cardiac support device might be beneficial for the treatment of ischemic cardiomyopathy.
METHODS: Twenty-four dogs with induced anterior wall infarction were assigned randomly to 1 of 4 groups at 1 week postinfarction as follows: cardiac support device alone, cardiac support device plus ONO-1301 (hybrid therapy), ONO-1301 alone, or sham control.
RESULTS: At 8 weeks post-infarction, LV wall stress was reduced significantly in the hybrid therapy group compared with the other groups. Myocardial blood flow, measured by positron emission tomography, and vascular density were significantly higher in the hybrid therapy group compared with the cardiac support device alone and sham groups. The hybrid therapy group also showed the least interstitial fibrosis, the greatest recovery of LV systolic and diastolic functions, assessed by multidetector computed tomography and cardiac catheterization, and the lowest plasma N-terminal pro-B-type natriuretic peptide levels (P < .05).
CONCLUSIONS: The combination of a cardiac support device and the prostacyclin agonist ONO-1301 elicited a greater reversal of LV remodeling than either treatment alone, suggesting the potential of this hybrid therapy for the clinical treatment of ischemia-induced heart failure.
Authors:
Yasuhiko Kubota; Shigeru Miyagawa; Satsuki Fukushima; Atsuhiro Saito; Hiroshi Watabe; Takashi Daimon; Yoshiki Sakai; Toshiaki Akita; Yoshiki Sawa
Related Documents :
23602297 - Stroke and ventricular arrhythmias.
24001437 - Metabolic syndrome and right ventricle: an updated review.
24113327 - Cellular encapsulation enhances cardiac repair.
23612897 - Therapeutic cardiac-targeted delivery of mir-1 reverses pressure overload-induced cardi...
19049767 - Ablation of ganglionic plexi during combined surgery for atrial fibrillation.
12908757 - Intracranial giant cell arteritis with fatal middle cerebral artery territory infarct.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-10-13
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  -     ISSN:  1097-685X     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-10-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Affiliation:
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic sign...
Next Document:  The High-affinity Maltose Switch MBP317-347 has Low Affinity for Glucose: Implications for Targeting...